Role of autophagy in disease and tumour robbins based answer for md pathology exam

Reading File

Finding Sources

Searching PubMed

autophagy AND cancer

Searching the Web

autophagy disease cancer role review 2025

Reading File

Finding Sources

Reading File

Autophagy: role in disease and tumourigenesis

Definition and mechanism

Autophagy is a lysosome-mediated process by which cells degrade their own cytoplasmic components, including damaged organelles, protein aggregates, and portions of cytoplasm. It is an adaptive response to nutrient deprivation and cellular stress.

Sequence:

Formation of an isolation membrane or phagophore
Enclosure of cytoplasmic material in a double-membrane autophagosome
Fusion of autophagosome with lysosome to form an autophagolysosome
Lysosomal degradation and recycling of metabolites

Autophagosome formation is controlled by autophagy-related (ATG) proteins. Lipidated LC3 is a useful marker of autophagy.
Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 51.

Physiological significance

Autophagy maintains cellular homeostasis by:

Providing metabolic substrates during starvation
Removing damaged mitochondria, ER and lysosomes
Eliminating misfolded protein aggregates
Limiting oxidative stress and accumulation of reactive oxygen species
Assisting intracellular pathogen clearance
Supporting survival of atrophic cells under severe nutrient deprivation

If cellular stress is overwhelming or sustained, autophagy may coexist with or be followed by apoptosis, necroptosis or ferroptosis. However, whether excessive autophagy itself directly causes cell death remains uncertain.
Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 51.

Role of autophagy in disease

1. Neurodegenerative diseases

Autophagy is needed for disposal of abnormal protein aggregates and dysfunctional organelles. Impaired autophagy aggravates defective proteostasis and neuronal injury.

Alzheimer disease: defective autophagosome maturation; genetic defects in autophagy accelerate neurodegeneration in experimental models.
Huntington disease: mutant huntingtin interferes with autophagy.
Similar autophagy-lysosome dysfunction contributes to accumulation of abnormal proteins in other neurodegenerative disorders.

Exam line: Failure of autophagy permits accumulation of toxic protein aggregates and damaged mitochondria, promoting neuronal dysfunction and death.
Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 51.

2. Infectious diseases

Autophagy, particularly xenophagy, is an intracellular host-defense mechanism.

It targets organisms such as mycobacteria, Shigella, and HSV-1 for lysosomal degradation.
Degradation of microbial proteins also facilitates antigen presentation.
Macrophage-specific loss of Atg5 increases susceptibility to tuberculosis.

Exam line: Autophagy links innate elimination of intracellular microbes with antigen processing.
Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 51.

3. Inflammatory bowel disease

Polymorphisms in ATG16L1 are associated with Crohn disease and ulcerative colitis.

Defective autophagy may impair:

Paneth-cell function and antimicrobial peptide handling
Clearance of intracellular bacteria
Regulation of mucosal innate immunity

This favors persistent intestinal inflammation.
Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 51.

4. Aging and degenerative states

With aging and repeated cellular stress, protein aggregates and damaged organelles accumulate. Reduced autophagic clearance contributes to impaired cellular homeostasis, oxidative stress, and age-associated degenerative disease.

Autophagy in cancer: a dual role

High-yield statement:

Autophagy can act as both a tumour suppressor and a tumour promoter, depending on the stage of tumour development and tumour microenvironment.

A. Autophagy as a tumour suppressor

In early carcinogenesis, effective autophagy protects against malignant transformation.

Mechanisms

Removes damaged mitochondria, thereby reducing ROS production
Removes protein aggregates and damaged cellular constituents
Limits chronic cellular injury, inflammation and genomic instability
Prevents persistence of metabolically damaged cells
Facilitates growth arrest or death of severely stressed cells rather than allowing survival with mutations

Genes promoting autophagy can have tumour-suppressor activity. Loss of autophagy therefore may enhance tumour growth.

Robbins concept: Tumour cells may grow in marginal environmental conditions without appropriately activating autophagy, implying that pathways that normally induce autophagy are disabled. This loss can favor tumour development.
Robbins, Cotran & Kumar Pathologic Basis of Disease, Chapter 7, “Autophagy”.

B. Autophagy as a tumour promoter

Once a tumour is established, autophagy may help malignant cells survive hostile conditions.

Mechanisms

Recycles intracellular proteins, lipids and organelles to provide carbon sources and energy
Enables survival during hypoxia, nutrient deprivation and oxidative stress
Supports tumour-cell survival in a poorly vascularized microenvironment
Promotes survival during tumour dormancy
May enable resistance to chemotherapy, radiotherapy and other treatments that preferentially kill actively proliferating cells

Thus, autophagy can permit tumour cells to “hibernate” during metabolic stress and later resume proliferation. This may contribute to therapeutic failure and recurrence.

Robbins, Cotran & Kumar Pathologic Basis of Disease, Chapter 7, “Autophagy”.

Tumour suppressor versus tumour promoter: table

Setting	Predominant role of autophagy	Effect
Normal cells and early carcinogenesis	Tumour suppressive	Clears damaged organelles/proteins, limits ROS, injury, inflammation and genomic instability
Nutrient-poor, hypoxic established tumour	Cytoprotective and tumour promoting	Provides metabolites and energy for survival
Dormant tumour cells	Promotes persistence	Allows prolonged survival under adverse conditions
During therapy	May promote treatment resistance	Supports survival of stressed, non-dividing tumour cells

Conclusion for examination

Autophagy is primarily a cellular survival and quality-control mechanism mediated through autophagosome-lysosome fusion. Defective autophagy contributes to neurodegeneration, infections, inflammatory bowel disease and age-related cellular damage. In cancer, its role is context-dependent: loss of autophagy may promote tumour initiation, whereas autophagy in established tumours may support metabolic adaptation, dormancy and treatment resistance. Hence, autophagy is described in Robbins as a tumour’s “friend or foe.”

This is a shared conversation. Sign in to Orris to start your own chat.